Mylan, Inc. (Nasdaq: MYL) today announced that Zyomyx's MyT4™ point-of-care CD4 diagnostic test has received the CE Certificate of Conformity in the European Union, an important step toward launching this innovative test and expanding ...
Tags: Mylan, Zyomyx's MyT4™point-of-care CD4, diagnostic test, HIV
The British Standards Institute (BSI) has awarded ISO 13485: 2003 certification to Zyomyx's quality management system. Zyomyx is involved in developing and commercializing proprietary diagnostic platforms including quantitative disposable ...
Tags: Zyomyx, CD4 diagnostics, proprietary diagnostic platforms